That the Parliament congratulates the University of Strathclyde and world-leading pharmaceutical company GlaxoSmithKline (GSK) on the first ever initiative in the United Kingdom to deliver a bespoke postgraduate MPhil chemistry degree programme; pays tribute to the expertise and professionalism of the university staff in achieving this outcome; recognises that this unique research programme will be geared towards identifying and developing novel treatments for a range of diseases, including respiratory, inflammatory, neurological and psychiatric diseases; acknowledges the potential that this will have to deliver considerable benefits for patients and public health; commends this innovative initiative as a tangible demonstration of the benefits of collaboration, in particular the knowledge exchange between academia and industry, and notes that the programme is designed to allow GSK employees to develop novel research approaches towards new treatments and, in so doing, aims to benefit society as a whole.